Table 3.
Correlation between snoRNA expression in FFPE and clinicopathologic characteristics of RCC patients
| Characteristics | Cases | SNORD15A | SNORD35B | SNORD60 | |
|---|---|---|---|---|---|
| P Value | P Value | P Value | |||
| Gender | Male | 20 | 0.6442 | 0.7683 | 0.7851 |
| Female | 16 | ||||
| Age | >=50 | 27 | 0.5284 | 0.5653 | 0.1932 |
| < 50 | 9 | ||||
| T stage | T1 | 6 | 0.7391 | 0.2409 | 0.3939 |
| T2 | 10 | ||||
| T3 | 11 | ||||
| T4 | 9 | ||||
| Lymph node metastasis | N0 | 21 | 0.7559 | 0.8559 | 0.8262 |
| N1 | 15 | ||||
| Distant metastasis | M0 | 35 | -- | -- | -- |
| M1 | 1 | ||||
| TNM stage | I | 13 | 0.4363 | 0.0086* | 0.7427 |
| II | 9 | ||||
| III | 13 | ||||
| IV | 1 | ||||
| Grade | G1G2 | 24 | 0.5282 | 0.9200 | 0.4453 |
| G3G4 | 9 | ||||
| Not Available | 3 | ||||
* Bold value, p < 0.05